BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6180643)

  • 1. No effect of intrarenal converting enzyme inhibition on canine renal blood flow.
    Zimmerman BG; Wong PC; Kounenis GK; Kraft EJ
    Am J Physiol; 1982 Aug; 243(2):H277-83. PubMed ID: 6180643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intrarenal and extrarenal converting-enzyme inhibition by SQ 20 881 on canine renal blood flow.
    Wong PC; Zimmerman BG
    Clin Sci (Lond); 1981 Nov; 61(5):553-7. PubMed ID: 6169480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of systemic and intrarenal converting enzyme inhibition by MK-422 on renal hemodynamics in conscious dogs.
    Zimmerman BG; Finis CJ
    J Cardiovasc Pharmacol; 1985; 7(4):715-22. PubMed ID: 2410713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
    Shannon RP; Friedrich S; Mathier M; Knight DR
    Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F522-9. PubMed ID: 2180318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS; Gavras H; Hood WB
    J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
    Chiba S; Quilley CP; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of a primary antidiuretic action of angiotensin II: effects of intrarenal converting enzyme inhibition in the conscious dog.
    Levens NR; Peach MJ; Vaughan ED; Carey RM
    Endocrinology; 1981 Jan; 108(1):318-30. PubMed ID: 6161801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in the renal responses to intravenous and renal artery infusions of noradrenaline in conscious dogs.
    Anderson WP; Korner PI; Selig SE
    J Physiol; 1981 Dec; 321():21-30. PubMed ID: 7040635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrarenal converting enzyme inhibition in rabbit.
    Li T; Zimmerman BG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S133-6. PubMed ID: 2485048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence of renal vasodilator effect of captopril on prevailing plasma renin level in the dog: influence of DOCA-salt treatment.
    Wong PC; Zimmerman BG
    Clin Sci (Lond); 1982 Oct; 63(4):355-60. PubMed ID: 7049508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.
    Haverdings RF; Haas M; Navis G; Van Loenen-Weemaes AM; Meijer DK; De Zeeuw D; Moolenaar F
    Br J Pharmacol; 2002 Aug; 136(8):1107-16. PubMed ID: 12163343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic nerve and hemodynamic responses to captopril in conscious dogs: role of prostaglandins.
    Zucker IH; Chen JS; Wang W
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H260-6. PubMed ID: 1899541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.